CrushSCI.com
148.6Average days
124Median days
26Fastest days
573Longest days
1832025 publications

Paper Review Records

All Paper Review Records

15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

137 days

Inarigivir exhibits RIG-I-independent antiviral activity against HBV DNA replication in vitro by inhibiting viral polymerase activity

Authors
Jun-Jie Zhang; Danni Colledge; Andrea Jurado; Ning Sun; Hu Zhang; Kathy Jackson; Vitina Sozzi; Xin Li; Nicholas S. Eyre; Michael R. Beard; Radhakrishnan Iyer; Nezam Afdhal; Haitao GuoShow moreShow less
Affiliations
Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN, USA; Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia; Department of Microbiology and Molecular Genetics; Cancer Virology Center, UPMC Hillman Cancer Center, Pittsburgh, PA, USA; Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia; Research Centre for Infectious Diseases, School of Biological Sciences, Adelaide University, Adelaide, South Australia, Australia; SR Biosciences Inc., Pullman, WA, USA; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USAShow moreShow less
Source PDF DOI Publisher page
55 days

Antiviral activity of amenamevir alone and in combination with ganciclovir against equine herpesvirus 1

Authors
Yoshinori Kambayashi; Erika S. Hue; Camille Normand; Christine Fortier; Thomas Barnoux; Hiroshi Bannai; Koji Tsujimura; Manabu Nemoto; Nanako Kawanishi; Guillaume Fortier; Stéphane PronostShow moreShow less
Affiliations
LABÉO, Saint-Contest, 14280, France; Université Caen Normandie, Normandie Univ, BIOTARGEN UR7450, IMPEDANCELL, Normandie Equine Vallée, GIS CENTAURE, Caen, F-14000, France; Equine Research Institute, Japan Racing Association, 1400-4 Shiba, Shimotsuke, Tochigi, 329-0412, JapanShow moreShow less
Source PDF DOI Publisher page
124 days

NF-κB–driven repression of Nrf2 facilitates HSV-1 replication in SH-SY5Y neuroblastoma and HeLa epithelial cells

Authors
Eduardo I. Tognarelli; Daniel A. Cornejo; Exequiel J. del Campo; Rodrigo Reyes-Ramírez; Gerardo E. Ortiz; Aracelly Gaete-Argel; Alexis M. Kalergis; Susan M. Bueno; Leandro J. Carreño; Ricardo Soto-Rifo; Pablo A. GonzálezShow moreShow less
Affiliations
Millennium Institute on Immunology and Immunotherapy, Santiago, 8330025, Chile; Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, 8331150, Chile; Laboratorio de Virología Molecular y Celular, Núcleo Interdisciplinario de Microbiología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago, 8380453, Chile; Departamento de Endocrinología, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, 8331150, Chile; Núcleo Interdisciplinario de Farmacología e Inmunología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago, 8380453, ChileShow moreShow less
Source PDF DOI Publisher page
149 days

N70 S/Y155H combined mutation of neuraminidase of avian influenza H9N2 virus confers oseltamivir and zanamivir resistance and pathogenicity to mice

Authors
Shenyu Ma; Yuting Chen; Jianwen Zhu; Yuhan Zong; Keyu Cai; Zhonglong Yang; Wenlei Wang; Yunfei Guo; Yan Guo; Xinyue Duan; Ziyan Fang; Nan Zhu; Sujuan Chen; Pinghu ZhangShow moreShow less
Affiliations
Key Laboratory of the Jiangsu Higher Education Institutions for Integrated Traditional Chinese and Western Medicine in Senile Diseases Control, School of Traditional Chinese Medicine, Faculty of Medicine, Yangzhou University, 225009, China; College of Veterinary Medicine, Yangzhou University, Yangzhou, 225009, China; Jiangsu Key Laboratory of Zoonosis, Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou, Jiangsu, 225009, ChinaShow moreShow less
Source PDF DOI Publisher page
573 days

Unveiling the antiviral mechanism of A4S7: a synthetic antimicrobial peptide targeting dengue and other mosquito-borne enveloped virus infections

Authors
Ting-Chun Lin; Jeng-Wei Lu; Chia-Hsin Liu; Yung-Chih Wang; Yuanpu Peter Di; Yi-Jung HoShow moreShow less
Affiliations
Graduate Institute of Life Sciences, College of Biomedical Sciences, National Defense Medical University, Taipei, Taiwan, ROC; Department of Bioscience and Biotechnology, National Taiwan Ocean University, Keelung, Taiwan, ROC; Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark; The Finsen Laboratory, Rigshospitalet/National University Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan, ROC; Division of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan, ROC; Department of Environmental and Occupational Health, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA; School of Pharmacy & Graduate Institute of Pharmacy, College of Pharmacy, National Defense Medical University, Taipei, Taiwan, ROCShow moreShow less
Source PDF DOI Publisher page
93 days

High-yield production of immunogenic PV3 virus-like particle in yeast

Authors
Tian Chen; Qin Hong; Wenyu Han; Shuxia Wang; Cheng Lin; Jiaqi Yao; Chaoyang Lian; Qingwei Liu; Xiaoli Wang; Yanqiu Zhou; Yao Cong; Zhong HuangShow moreShow less
Affiliations
Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China; Key Laboratory of RNA Science and Engineering, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China; Huasong (Shanghai) Biomedical Technology Co., LTD, Shanghai, China; Chongqing Huazhi Biopharmaceutical Co., LTD, Chongqing, China; Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China; Key Laboratory of Systems Health Science of Zhejiang Province, School of Life Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, ChinaShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does ANTIVIRAL RESEARCH take to review a manuscript?

As of 2026-11-19, CrushSCI has 15 complete review records for ANTIVIRAL RESEARCH. The fastest paper went from submission to acceptance in 26 days (Antiviral profile of hepatitis B virus capsid assembly modulator ALG-001075, the parent of pevifoscorvir sodium, received 2026-07-15, accepted 2026-08-10); the slowest took 573 days. The average is 148.6 days and the median is 124 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.